Related Experiment Video
Updated: Aug 14, 2026

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
Published on: November 13, 2012
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET
K Herholz1, L W Kracht, W D Heiss
1Neurologische Universitätsklinik, Max-Planck-Institut für Neurologische Forschung, Gleueler Str 50, 50931 Köln, Germany. karl.herholz@pet.mpin-koeln.mpg.de
Abstract:
The effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.
More Related Videos
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

